Fluctuation of Serum Apelin Level during Pregnancy

Main Article Content

Sherif Wagih Mansour
Ali Khalil Asalah
Kamelia Ibrahim Attia
Somya E. l. Sayed Mohammed
Ahmad Desoky

Abstract

Background: Apelin is an endogenous ligand for the G protein-coupled receptor Apelin receptor (APJ), The expression of both apelin and APJ has been detected in a variety of tissues including  heart, brain ,ovary , placenta and uterus.


Aim of the Study: This study was designed to examine the circulating levels of apelin, estradiol, progesterone, glucose, insulin and Tumor necrosis Factor alpha (TNF α)  in non-pregnant, pregnant rats at different stages of  pregnancy.


Materials and Methods: Sixty adult albino rats (48 females and 12 males). Female rats were randomly divided into (non -pregnant rats, early pregnant rats on day 6 of gestation, mid pregnant rats on day 12 of gestation and rats late pregnant rats on day 19 of gestation. The blood samples were obtained from the orbital venous plexus of animals and serum was separated from each blood sample and kept deep frozen until analysed.


Results: The present study revealed that the serum levels of apelin were progressively  and significantly increased from early (day 6) to mid-pregnancy (day 12) of gestation when compared to non- pregnant rats then showed a marked decrease on day 19 when compared to pregnant rats on day 12 of gestation.


Conclusion: The fluctuations in serum apelin levels during pregnancy may be attributed to changes in serum levels of multiple interrelated factors such as insulin, insulin resistance, pro inflammatory cytokines such as TNF α and other factors such as changes in fat mass, the  expression of angiotensin converting enzyme related carboxy peptidase-2 (ACE 2) and hormonal levels during pregnancy.

Keywords:
Apelin, placenta, pregnancy

Article Details

How to Cite
Mansour, S., Asalah, A., Attia, K., Mohammed, S. E. l., & Desoky, A. (2019). Fluctuation of Serum Apelin Level during Pregnancy. Asian Journal of Medicine and Health, 15(2), 1-9. https://doi.org/10.9734/ajmah/2019/v15i230119
Section
Original Research Article

References

Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Fujino M. Molecular properties of apelin: Tissue distribution and receptor binding. Biochimica et Biophysica Acta. 2001;1538 (2–3):162–171.

O’Carroll AM, Selby TL, Palkovits M, Lolait SJ. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochimica et Biophysica Acta - Gene Structure and Expression. 2000;1492(1):72–80.

Shirasuna K, Shimizu T, Sayama K, Asahi T, Sasaki M, Berisha B, Miyamoto A. Expression and localization of apelin and its receptor APJ in the bovine corpus luteum during the estrous cycle and prostaglandin F2 - induced luteolysis. Reproduction. 2008;135:525.

Mayeur S, Wattez JS, Lukaszewski MA, Lecoutre S, Butruille L, Drougard A, Lesage J. Apelin controls fetal and neonatal glucose homeostasis and is altered maternal undernutrition. Diabetes. 2016;65(3):554–560.

Josephs T, Waugh H, Kokay I, Grattan D, Thompson M. Fasting-induced adipose factor identified as a key adipokine that is up-regulated in white adipose tissue during pregnancy and lactation in the rat. Journal of Endocrinology. 2007;194(2):305– 312.

Mieghem TV, Bree RV, Herck EV, Pijnenborg R, Deprest J, Verhaeghe J. Maternal apelin physiology during rat pregnancy : The role of the placenta. Placenta. 2010;31(8):725–730.

Kacar E, Ercan Z, Serhatlioglu I, Sumer A, Kelestimur H, Kutlu S. The effects of apelin on myometrium contractions in pregnant rats. Cellular and Molecular Biology (Noisy-Le-Grand, France). 2018;64(11):74–79.

Kourtis A, Gkiomisi A, Mouzaki M, Makedou K, Anastasilakis AD, Toulis KA, Agorastos T. Apelin levels in normal pregnancy. Clinical Endocrinology. 2011;75(3);367–371.

Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: A Prospective Study1. The Journal of Clinical Endocrinology & Metabolism. 1998;83(9):3078–3082.

Goldman inical endocrinology & metabolism.2007;83(9):3078–3082.

Scorza Barcellona P, Fanelli O, Campana A. Teratological study of etoperidone in the rat and rabbit. Toxicology. 1977;8:87–94.

Klukovits A, Gáspár R, Sántha P, Jancsó G, Falkay G. Functional and histochemical characterization of a uterine adrenergic denervation process in pregnant rats. Biol. Reprod. 2002;67:1013–7.

Sladek SM, Roberts JM. Nitric oxide synthase activity in the gravid rat uterus decreases a day before the onset of parturition. Am. J. Obstet. Gynecol. 1996; 175:1661–7 .

Peters M, Meyer zum Büschenfelde KH, Rose-John S. The function of the soluble IL-6 receptor in vivo. Immunology Letters. 1996;54(2–3):177–184.

Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002;51(9):2734–2741.

Porstmann T, Kiessig ST. Enzyme immunoassay techniques. An overview. Journal of Immunological Methods. 1992; 150(1–2):5–21.

Tietz NW ed.: Clinical guide to laboratory tests, 3rd ed. Philadelphia, WB Saunders. 1995;509–512.

Temple RC, Clark PM, Hales CN. Measurement of insulin secretion in type 2 diabetes: problems and pitfalls. Diabetic Medicine. 1992;9:503-512.

Sun G, Bishop J, Khalili S, Vasdev S, Gill V, Pace D, et al. Serum visfatin concentrations are positively correlated with serum triacylglycerols and down regulated by overfeeding in healthy young men. Am J Clin Nutr. 2007;85(2):399-404.

Medhurst A, Jennings C, Robbins M, Davis R, Ellis C, Winborn K, Darker JG. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. 2003;1162–1172.

Telejko B, Kuzmicki M, Wawrusiewicz-Kurylonek N, Szamatowicz J, Nikolajuk A, Zonenberg A, Gorska M. Plasma apelin levels and apelin/APJ mRNA expression in patients with gestational diabetes mellitus. Diabetes Research and Clinical Practice. 2010;87(2):176–183.

Kalea AZ, Batlle D. Apelin and ACE2 in cardiovascular disease. Current Opinion in Investigational Drugs. 2010;11(3):273–282.

McKinnie SM, Fischer C, Tran KM, Wang W, Mosquera F, Oudit GY, Vederas JC. The metalloprotease neprilysin degrades and inactivates apelin peptides. Chem Bio Chem. 2016;17(16):1495-1498.‏

Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764–1771..

Hadden DR, McLaughlin C. Normal and abnormal maternal metabolism during pregnancy. Seminars in Fetal and Neonatal Medicine. 2009;14(2):66–71.

Freemark M. Regulation of maternal metabolism by pituitary and placental hormones: Roles in fetal Development and Metabolic Programming. Hormone Research. 2006;65(Suppl. 3):41– 49.

Paradisi G, Biaggi A, Ferrazzani S, De Carolis S, Caruso A. Abnormal carbohydrate metabolism during pregnancy : Association with endothelial dysfunction. Diabetes Care. 2002;25(3): 560–564.

Zhang Y, Shen C, Li X, Ren G, Fan X, Ren F, Yang J. Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people. Diabetes Care. 2009;32(12):e150.

Castan-Laurell I, Vítkova M, Daviaud D, Dray C, Kováčiková M, Kovacova Z, Valet P. Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ. European Journal of Endocrinology. 2008;158(6):905–910.

Freemark M. Placental hormones and the control of fetal growth. Journal of Clinical Endocrinology and Metabolism. 2010;95(5):2054–2057.

Garcı́a-Arencibia M, Molero S, Dávila N, Carranza MC, Calle C. 17β-Estradiol transcriptionally represses human insulin receptor gene expression causing cellular insulin resistance. Leukemia research, 2005;29(1):79-87.‏

Kumar P, Magon N. (2012). Hormones in pregnancy. Nigerian Medical Journal : Journal of the Nigeria Medical Association. 2012;53(4):179–183.

Li Y, Wang Y, Ding X, Duan B, Li L, Wang X. Serum levels of TNF- a and IL-6 are associated with pregnancy-induced hypertension. 2016;1–7.

Gad HI. The potential role of anti tumor necrosis factor-alpha anti bodies on some renal functions and vasoregulatory factors in preeclamptic pregnant Wistar rats. Saudi Medical Journal. 2013;34(5):490–496.

Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, Quilliot D, Castan-Laurell I. TNFα up-regulates apelin expression in human and mouse adipose tissue. The FASEB Journal. 2006;20(9):1528–1530.

Minuz P, Fava C, Hao S, Pedraza P, Amen G, Meneguzzi A, Ferreri NR. Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia. Journal of Maternal-Fetal and Neonatal Medicine. 2015;28(8): 869– 875.

Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M, and Post M. Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest. 2000;105:577–587.

O’Carroll AM, Lolait SJ, Howell GM. Transcriptional regulation of the rat apelin receptor gene: Promoter cloning and identification of an Sp1 site necessary for promoter activity. Journal of Molecular Endocrinology. 2006;36(1):221–235.

He L, Xu J, Chen L, Li L. Apelin/APJ signaling in hypoxia-related diseases. Clinica Chimica Acta. 2015;451(Pt B): 191–198.

Dray C, Debard C, Jager J, Disse E, Daviaud D, Martin P, Castan-Laurell I. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. American Journal of Physiology-Endocrinology and Metabolism. 2010;298(6):E1161–E1169.